NIIMBL (The National Institute for Innovation in Manufacturing Biopharmaceuticals)

The National Institute for Innovation in Manufacturing Biopharmaceuticals ( NIIMBL ) is pleased to announce Project Call 10.1 for technology and workforce development projects. NIIMBL expects to launch a combined $8 million of project activities to address U.S. competitiveness in biopharmaceutical manufacturing.

Concept submissions are due...

NIIMBL’s Viral Vector Program has selected eight teams to participate in an interlaboratory study focused on improving the accuracy of AAV9 capsid titer measurements. The goal is to enhance consistency in manufacture of gene therapy products.

The selected teams are:

Last week, more than 400 representatives from the NIIMBL community joined in Washington, D.C. and virtually for the 2026 National Meeting. The meeting delivered the familiar mix of inspiring plenaries, expert‑led sessions, and member‑driven idea‑sharing that defines our annual event.

The program also highlighted standout contributions from across...